- Home
- ZLAB vs JBLU Comparison
ZLAB vs JBLU Comparison
Compare ZLAB & JBLU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- JBLU
- Stock Information
- Founded
- ZLAB 2013
- JBLU 1998
- Country
- ZLAB China
- JBLU United States
- Employees
- ZLAB N/A
- JBLU N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- JBLU Air Freight/Delivery Services
- Sector
- ZLAB Health Care
- JBLU Consumer Discretionary
- Exchange
- ZLAB Nasdaq
- JBLU Nasdaq
- Market Cap
- ZLAB 3.6B
- JBLU 1.5B
- IPO Year
- ZLAB 2017
- JBLU N/A
- Fundamental
- Price
- ZLAB $32.54
- JBLU $4.39
- Analyst Decision
- ZLAB Buy
- JBLU Sell
- Analyst Count
- ZLAB 5
- JBLU 11
- Target Price
- ZLAB $54.28
- JBLU $4.97
- AVG Volume (30 Days)
- ZLAB 781.8K
- JBLU 19.3M
- Earning Date
- ZLAB 08-05-2025
- JBLU 07-29-2025
- Dividend Yield
- ZLAB N/A
- JBLU N/A
- EPS Growth
- ZLAB N/A
- JBLU N/A
- EPS
- ZLAB N/A
- JBLU N/A
- Revenue
- ZLAB $418,326,000.00
- JBLU $9,210,000,000.00
- Revenue This Year
- ZLAB $44.07
- JBLU N/A
- Revenue Next Year
- ZLAB $49.13
- JBLU $7.75
- P/E Ratio
- ZLAB N/A
- JBLU N/A
- Revenue Growth
- ZLAB 43.72
- JBLU N/A
- 52 Week Low
- ZLAB $16.01
- JBLU $3.34
- 52 Week High
- ZLAB $44.34
- JBLU $8.31
- Technical
- Relative Strength Index (RSI)
- ZLAB 40.19
- JBLU 47.73
- Support Level
- ZLAB $34.26
- JBLU $4.18
- Resistance Level
- ZLAB $35.72
- JBLU $4.81
- Average True Range (ATR)
- ZLAB 1.12
- JBLU 0.23
- MACD
- ZLAB -0.54
- JBLU 0.03
- Stochastic Oscillator
- ZLAB 3.83
- JBLU 56.70
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About JBLU JetBlue Airways Corporation
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The company has one operating segment, Air Transportation Services, which provides services in the United States, the Caribbean, Latin America, Canada, and Europe. The majority of revenue is generated from the Domestic & Canada segment.